U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
[ ] Form 10-K [ ] Form 20F [ ] Form 11-K [X] Form 10-Q
[ ] Form N-SAR
For the Period Ended September 30, 2003.
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended ________________
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
If the notification relates to a portion of the filing
checked above, identify the Item(s) to which the notification
relates:
PART I - REGISTRANT INFORMATION
Full Name of Registrant: Omni Medical Holdings, Inc.
Address of Principal 1107 Mt. Rushmore Road, Suite 2
Executive Office: Rapid City, South Dakota 57701
PART II - RULES 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable
effort or expense and the Registrant seeks relief pursuant to
Rule 12b-25(b) [Section 23,047], the following should be completed.
(Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part
III of this form could not be eliminated without unreasonable
effort or expense;
[ ] (b) (i) The subject annual report, semi-annual
report, transition report on Form 10-K, Form 20F, 11-K or Form
N-SAR, or portion thereof will be filed on or before the
fifteenth calendar day following the prescribed due date; or
[X] (ii) The subject quarterly report or transition
report on Form 10-Q, or portion thereof will be filed on or
before the fifth calendar day following the prescribed due date.
[ ] (c) The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
The Company has changed accountants and will need additional time to
prepare the unaudited reviewed financial statements to be filed with the
Company's 10-QSB Quarterly Report for the quarter ended September 30, 2003.
The 10-QSB will be filed within the 5 calendar day extension, or by November
19, 2003.
PART IV - OTHER INFORMATION
(1) Name and address of person to contact in regard to
this notification:
Leonard W. Burningham, Esq.
455 East 500 South, Suite 205
Salt Lake City, Utah 84111
Telephone: (801) 363-7411
(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed? If
the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[X] Yes [ ] No
On September 5, 2003, the Registrant completed the merger of Piezo
Instruments, Inc. with Omni Medical of Nevada, Inc. following which the
stockholders and management of Omni Medical of Nevada, Inc. acquired control
of Piezo Instruments, Inc. The merger has been treated as a reverse merger
for accounting purposes and as a result, the Results of Operations for the
three and six months ended September 30, 2003, are the historical results of
Omni Medical of Nevada, Inc. Omni Medical of Nevada, Inc. has a March 31,
fiscal year end.
The Registrant is unable to provide an accurate quantitative
estimate of the quarterly results for the three months and six months ended
September 30, 2003, as it has not yet completed certain steps necessary to
provide such an estimate.
OMNI MEDICAL HOLDINGS, INC. has caused this notification to be
signed on its behalf by the undersigned thereunto duly authorized.
Date: 11/13/03 /s/ Arthur D. Lyons
--------- ----------------------------
Arthur D. Lyons
President and Director